HeartBeam, Inc. BEAT 深 滬
等待開盤 01-28 09:30:00 美东时间
1.78
+0.010
+0.56%
華盛通- 最 高1.805
- 今 開1.74
- 成交量 48.88万股
- 最 低 1.725
- 昨 收 1.77
- 總市值 6018.13万
- 52周最高 4.00
- 市盈率 靜 --
- 換手率 1.45%
- 52周最低 0.54
- 委 比 67.82%
- 總股本 3380.97万
- 歷史最高 71.96
- 量 比 0.50
- 振 幅 4.52%
- 歷史最低 0.54
- 每 手 1
- 風險率 0.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
Austin, Texas, United States, January 22nd, 2026, FinanceWire HeartBeam (NASDAQ...
01-23 01:00
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer HeartBeam Inc. has appointed Bryan Humbarger as Chief Commercial Officer. Humbarger will lead the commercialization of HeartBeam’s FDA-cleared 12-lead ECG system for arrhythmia assessment and guide broader growth initiatives, including h
01-22 20:00
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
Austin, Texas, United States, January 12th, 2026, FinanceWire HeartBeam (NASDAQ...
01-12 23:30
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ:...
01-06 01:00
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
Austin, Texas, United States, December 18th, 2025, FinanceWire HeartBeam (NASDA...
2025-12-19 02:00
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket
Shares of Aditxt Inc (NASDAQ:ADTX) rose sharply in pre-market trading following...
2025-12-17 17:35
美股牛股 | B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%
B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%，预计年度经常性收入突破2亿美元，大幅超越此前目标>>
2025-12-17 18:50
3 Penny Stocks to Watch Now, 12/16/25
cbdMD, iRobot, and HeartBeam are the 3Penny Stocksto watch on Decem...
2025-12-16 23:29
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
